Effects of Reiki and Self-Acupressure Applications

NCT ID: NCT07083856

Last Updated: 2025-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-20

Study Completion Date

2025-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Reiki, the subject of our research, is a complementary medicine practice within energy approaches. Discovered in Sanskrit texts by Dr. Usui in Japan in the late 19th century, it was demonstrated through studies demonstrating its effectiveness in symptoms of pain, depression, insomnia, and fatigue. Everything in the universe, including the human body, is composed of energy; any disruption in this energy can lead to illness. There are seven chakras where Reiki is applied. The main chakra centers are located along the spine. During Reiki treatments, the hands are held in each position, touching the head, neck, chest, abdominal cavity, and groin for 3-5 minutes. This period may extend to 10-20 minutes in problematic areas. The average treatment duration is 30-90 minutes. During the treatment, the patient lies down or reclines, and there is no need to remove clothing. During Reiki treatment, individuals may report a slight warming sensation under or near the therapist's hand. The only rule in Reiki practice is that the individual gives the practitioner permission to facilitate the flow of energy. The person receiving Reiki does not need to believe in Reiki during the treatment. Reiki is a universal life energy present in everyone. Reiki is generally safe, and no serious side effects have been reported. Over the last 10 years, Reiki practice has been increasing among physicians, nurses, and other healthcare professionals. This study will compare the effects of acupressure and Reiki treatments on functionality and quality of life in patients with multiple sclerosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors
The groups doing the analysis will do the analysis without knowing it.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Reiki group

Group where Reiki was applied

Group Type EXPERIMENTAL

Reiki

Intervention Type BEHAVIORAL

Reiki

Self-acupressure applied group

Group where Self-acupressure was applied

Group Type EXPERIMENTAL

Self-Acupressure

Intervention Type BEHAVIORAL

Self-Acupressure

Control

Group with no intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reiki

Reiki

Intervention Type BEHAVIORAL

Self-Acupressure

Self-Acupressure

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients who are willing to participate
2. Patients who have no communication problems
3. Patients who are 18 years of age or older
4. Patients who live in the center
5. Patients who have no scratches or deformities in the treatment area
6. Patients who do not smoke, use drugs, or use tranquilizers, and are not pregnant
7. Patients who have been receiving MS treatment for more than three months

Exclusion Criteria

1. Patients who smoke, use substances, or use tranquilizers
2. Have dyspnea
3. Have anemia
4. Have diabetes
5. Have received corticosteroid treatment in the last three months
6. Have had an MS attack in the last three months
7. Have an autoimmune disease other than multiple sclerosis
8. Have signs of infection
9. Have a thyroid problem
10. Are taking psychostimulant medications
11. Have anxiety or depression detected in outpatient clinic screenings
12. Refuse to participate in the study
13. Have another known neurological system disease (dementia, Alzheimer's, etc.)
14. Have a communication barrier will not be included in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Firat University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Furkan BİLEK

PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Caner F Demir, MD

Role: STUDY_CHAIR

Firat University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Muğla Sıtkı Koçman University

Muğla, Fethi̇ye, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Furkan Bilek, PhD

Role: CONTACT

+905442772249

Furkan Bilek

Role: CONTACT

05442772249

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Furkan Bilek

Role: primary

05442772249

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022/ 11- 14

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Usability of the MeTime MS App
NCT07123272 COMPLETED NA
Acupuncture and Pain Processing
NCT01270607 COMPLETED NA